title: Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.
abstract: BACKGROUND
  Calcimimetic agents lower serum parathyroid hormone levels in people with chronic kidney disease (CKD), but treatment effects on patient-relevant outcomes are uncertain. We conducted a systematic review and meta-analysis to summarize the benefits and harms of calcimimetic therapy in adults with CKD and used cumulative meta-analysis to identify how evidence for calcimimetic treatment has developed in this clinical setting.
  
  
  RESULTS
  Cochrane and Embase databases (through February 7, 2013) were electronically searched to identify randomized trials evaluating effects of calcimimetic therapy on mortality and adverse events in adults with CKD. Two independent reviewers identified trials, extracted data, and assessed risk of bias. Eighteen trials comprising 7,446 participants compared cinacalcet plus conventional therapy with placebo or no treatment plus conventional therapy in adults with CKD. In moderate- to high-quality evidence (based on Grading of Recommendations Assessment, Development, and Evaluation criteria) in adults with CKD stage 5D (dialysis), cinacalcet had little or no effect on all-cause mortality (relative risk, 0.97 [95% confidence interval, 0.89-1.05]), had imprecise effect on cardiovascular mortality (0.67 [0.16-2.87]), and prevented parathyroidectomy (0.49 [0.40-0.59]) and hypercalcemia (0.23 [0.05-0.97]), but increased hypocalcemia (6.98 [5.10-9.53]), nausea (2.02 [1.45-2.81]), and vomiting (1.97 [1.73-2.24]). Data for clinical outcomes were sparse in adults with CKD stages 3-5. On average, treating 1,000 people with CKD stage 5D for 1 y had no effect on survival and prevented about three patients from experiencing parathyroidectomy, whilst 60 experienced hypocalcemia and 150 experienced nausea. Analyses were limited by insufficient data in CKD stages 3-5 and kidney transplant recipients.
  
  
  CONCLUSIONS
  Cinacalcet reduces the need for parathyroidectomy in patients with CKD stage 5D, but does not appear to improve all-cause or cardiovascular mortality. Additional trials in CKD stage 5D are unlikely to change our confidence in the treatment effects of cinacalcet in this population.
authors: Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
authors: Suetonia C
authors: SC
authors: Palmer
authors: Ionut
authors: I
authors: Nistor
authors: Jonathan C
authors: JC
authors: Craig
authors: Fabio
authors: F
authors: Pellegrini
authors: Piergiorgio
authors: P
authors: Messa
authors: Marcello
authors: M
authors: Tonelli
authors: Adrian
authors: A
authors: Covic
authors: Giovanni F M
authors: GF
authors: Strippoli
mesh_terms: D057966:Calcimimetic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002128:Calcium Metabolism Disorders / Q000209:etiology / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000401:mortality*; D000069449:Cinacalcet; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy / Q000601:surgery; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use*; D009325:Nausea / Q000209:etiology; D010281:Parathyroid Hormone / Q000097:blood*; D016105:Parathyroidectomy; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D014839:Vomiting / Q000209:etiology
chemical_list: D057966:Calcimimetic Agents; D009281:Naphthalenes; D010281:Parathyroid Hormone; D000069449:Cinacalcet
references: N Engl J Med. 2009 Apr 2;360(14):1395-407
references: 19332456
references: FASEB J. 2006 Dec;20(14):2562-4
references: 17077282
references: Nephrol Dial Transplant. 2008 Jan;23(1):328-35
references: 17717030
references: Stat Med. 2006 Oct 30;25(20):3443-57
references: 16345038
references: Am J Kidney Dis. 2004 Dec;44(6):1070-6
references: 15558528
references: Kidney Int. 2005 Oct;68(4):1793-800
references: 16164656
references: Ther Apher Dial. 2011 Dec;15(6):547-55
references: 22107691
references: Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
references: 11904577
references: JAMA. 2010 Feb 3;303(5):423-9
references: 20124537
references: J Am Soc Nephrol. 2002 Apr;13(4):1017-1024
references: 11912261
references: N Engl J Med. 2002 Dec 19;347(25):2010-9
references: 12490682
references: N Engl J Med. 2005 Jul 21;353(3):238-48
references: 16034009
references: Clin J Am Soc Nephrol. 2008 Jan;3(1):36-45
references: 18178780
references: Am J Kidney Dis. 2005 Jul;46(1):58-67
references: 15983958
references: Ann Intern Med. 2007 Dec 18;147(12):840-53
references: 18087055
references: Arch Intern Med. 2008 Feb 25;168(4):397-403
references: 18299495
references: BMJ. 2008 Apr 26;336(7650):924-6
references: 18436948
references: N Engl J Med. 2004 Sep 23;351(13):1296-305
references: 15385656
references: Am J Kidney Dis. 2009 Feb;53(2):197-207
references: 19110359
references: Clin J Am Soc Nephrol. 2008 Sep;3(5):1487-93
references: 18650409
references: Kidney Int. 2010 Sep;78(6):578-89
references: 20555319
references: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006254
references: 17054287
references: Biochem Biophys Res Commun. 2007 Oct 12;362(1):11-16
references: 17706605
references: Biometrics. 2000 Jun;56(2):455-63
references: 10877304
references: Am J Kidney Dis. 2006 Sep;48(3):392-401
references: 16931212
references: PLoS One. 2012;7(7):e39471
references: 22848355
references: Clin J Am Soc Nephrol. 2008 Nov;3(6):1718-25
references: 18945995
references: Nephrol Dial Transplant. 2011 Apr;26(4):1327-39
references: 21148030
references: Ann Intern Med. 2012 Mar 20;156(6):445-59
references: 22431677
references: J Am Soc Nephrol. 2003 Mar;14(3):575-83
references: 12595492
references: Kidney Int. 2003 Jan;63(1):248-54
references: 12472790
references: Lancet. 2007 Feb 3;369(9559):381-8
references: 17276778
references: Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006023
references: 21328279
references: Kidney Int. 2004 Jan;65(1):282-8
references: 14675061
references: N Engl J Med. 2012 Dec 27;367(26):2482-94
references: 23121374
references: Ther Apher Dial. 2008 Apr;12(2):117-25
references: 18387159
references: N Engl J Med. 2004 Apr 8;350(15):1516-25
references: 15071126
references: J Am Soc Nephrol. 2005 Mar;16(3):800-7
references: 15689407
references: Nephrol Dial Transplant. 2012 Aug;27(8):3270-8
references: 22387567
references: Clin Nephrol. 2008 Apr;69(4):269-78
references: 18397701
references: Kidney Int. 2000 Jul;58(1):436-45
references: 10886592